Repligen
RGEN
487 hedge funds and large institutions have $10.3B invested in Repligen in 2024 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 175 increasing their positions, 167 reducing their positions, and 34 closing their positions.
358% more call options, than puts
Call options by funds: $212M | Put options by funds: $46.4M
79% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 34
5% more funds holding
Funds holding: 466 → 487 (+21)
5% more repeat investments, than reductions
Existing positions increased: 175 | Existing positions reduced: 167
1% less capital invested
Capital invested by funds: $10.5B → $10.3B (-$112M)
3.27% less ownership
Funds ownership: 104.22% → 100.95% (-3.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$78M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$71.5M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$42.4M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.9M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$84.2M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$76.6M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$70.5M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$66.9M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$51.6M |
RGEN Hedge Fund Activity: Q1 2024 in Review
487 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2024, worth a combined $10.3B — down 1.1% from $10.5B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new RGEN positions and 34 closed out — a net gain of 27 holders — while 175 added to existing stakes and 167 trimmed.
The largest buyer was Invesco, adding an estimated $78M. The largest seller was T. Rowe Price Associates, cutting an estimated $84.2M.
- 487 institutional investors held Repligen (RGEN) as of Q1 2024, up from 466 in Q4 2023.
- Funds reported $10.3B of Repligen stock for Q1 2024, down 1.1% quarter-over-quarter.
- 61 funds opened new Repligen positions in Q1 2024 and 34 closed out, a net change of +27 holders.
- The largest Repligen buyer in Q1 2024 was Invesco, an estimated $78M added.
- The largest Repligen seller in Q1 2024 was T. Rowe Price Associates, an estimated $84.2M sold.
Based on aggregated 13F filings for Q1 2024.